Retatrutide is a newly developed therapy that acts as a powerful GLP-1 receptor stimulator. This breakthrough treatment holds significant promise for regulating type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide boosts insulin secretion and reduces glucagon release, leading to improved glycemic control. Clinical trials have d